Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Neurology
•
Vascular Neurology
•
Hospital Medicine
How do you manage acute ischemic stroke patients secondary to HUS/TTP?
Is there a certain platelet value cutoff that you would consider adding antithrombotics?
Related Questions
How do you manage patients with embolic stroke of an undetermined source and a papillary fibroelastoma found on an echocardiogram?
How to approach reversal of TNK in hemorrhagic conversion of ischemic stroke?
What is the utility of a hypercoagulability workup in recurrent cryptogenic stroke, and what specific tests would you recommend?
When do you consider lumbar spinal fluid drainage after acute spinal cord injury?
What is your recommended long term management of extensive dural venous sinus thrombosis in an otherwise healthy young patient?
What is your approach to management and surveillance in low grade traumatic blunt ICA injury?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How would you approach the upfront management of a patient with acute unilateral vision loss with strong clinical risk factors for both cardioembolic stroke and GCA if an expedited MRI is not possible due to the presence of an AICD?
What is your approach to managing patients who initially present with symptomatic intracranial large vessel occlusion but subsequently experience resolution of symptoms or become non-disabling before any intervention?
Should one perform a subsequent screening CTA or MRA head for mycotic aneurysm after cardio-embolic strokes in a setting of endocarditis with initial unremarkable CTA or MRA head/neck?